Biotech company Aldeyra Therapeutics saw its share price soar recently, following the positive outcome of its Phase 2A trials of...
Read moreMultinational healthcare giant Roche suffered a setback recently, after it was revealed geographic atrophy (GA) drug lampalizumab did not meet...
Read moreManagers play a leading role in establishing and fostering ployee engagent. PAUL KEIJER outlines five ways to improve staff motivation...
Read moreVisit Johnson and Johnson Vision's Showroom
Read moreAn innovative drug developed by Novartis to treat wet age-related macular degeneration (AMD) is set to challenge the market domination...
Read moreAllergan has agreed to pay US$13 million (AU$17.1 m) to settle a lawsuit brought against it by two US ophthalmologists...
Read moreLuxury brand Kering has denied accusations of false advertising after a lawsuit accused the company of falsely printing ‘Made in...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited